HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Goya V. Raikar Kunikazu Hisamochi Hartzell V. Schaff Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raikar, G. V. Articles by Schaff, H. V. Search for Related Content PubMed PubMed Citation Articles by Raikar, G. V. Articles by Schaff, H. V.

J Thorac Cardiovasc Surg 1996;111:1240-1247
© 1996 Mosby, Inc.

CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

NITRIC OXIDE INHIBITION ATTENUATES SYSTEMIC HYPOTENSION PRODUCED BY PROTAMINE

From the Cardiac Surgical Research Laboratory and the Section of Cardiovascular Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minn.

Received for publication June 21, 1995 Revisions requested Oct. 4, 1995; revisions received Oct. 9, 1995 Accepted for publication Jan. 18, 1996. Address for reprints: Hartzell V. Schaff, MD, Section of Cardiovascular Surgery, Mayo Clinic and Mayo Foundation, 200 First St. SW, Rochester, MN 55905.

Abstract

Background:Protamine reversal of heparin anticoagulation often causes systemic hypotension, and in vitro studies suggest that this may be mediated by release of nitric oxide from the endothelium. The present investigations were designed to evaluate the direct myocardial effects of protamine and to determine in vivo whether nitric oxide inhibition can prevent hypotension during protamine infusion. Methods/Results: Protamine sulfate (50µg/ml) was added to perfusate of eight isolated rabbit heart preparations; in six other preparations, a similar concentration of protamine was added to heparinized(5 U/ml) Krebs perfusate. Left ventricular developed pressure, maximum rate of pressure rise, and heart rate declined significantly (p< 0.01) in hearts exposed to protamine only (65.0% ± 6.6%, 55.5% ± 6.0%, and 87.6% ± 2.5% of baseline, respectively), whereas protamine added to heparinized perfusate caused little change in developed pressure, maximum rate of pressure rise, and heart rate (85.3% ± 5.4%, 84.9% ± 5.5%, and 98.8% ± 1.6%). To study systemic effects of protamine, we measured hemodynamic parameters in 12 heparinized dogs (150 U/kg). During protamine infusion (1.5 mg/kg intravenously over 30 seconds), mean blood pressure decreased by 46% ± 7% from baseline (p< 0.05), cardiac output decreased by 38% ± 4% (p< 0.05), and systemic vascular resistance decreased by 14% ± 9%. After hemodynamic stabilization, N^g-monomethyl-f123503d (2 mg/kg), a competitive inhibitor of nitric oxide synthesis, was administered to six dogs, and methylene blue (2 mg/kg), an inhibitor of cyclic guanosine monophosphate synthesis, was administered to the remaining six dogs. After treatment with N^g-monomethyl-L-arginine and methylene blue, the second infusion of protamine sulfate caused no significant change in blood pressure or cardiac output. In an additional six dogs, N^g-monomethyl-L-arginine pretreatment (5 mg/kg) blocked the effects of the first dose of protamine. The effect of N^g-monomethyl-L-arginine could be reversed by the addition of (6 mg/kg) L-arginine but not d-arginine. Conclusions:Protamine-heparin complex does not cause direct myocardial depression but does lead to severe hypotension in vivo. The finding that hypotension can be blocked by inhibitors of the nitric oxide pathway confirms previous in vitro studies indicating that the effects of protamine are mediated, in part, by the vascular endothelium. Further, these studies suggest a novel approach to prevention of hemodynamic complications caused by heparin reversal after cardiopulmonary bypass. (J THORAC CARDIOVASC SURG1996;111:1240-7)

This article has been cited by other articles:

				K. Takakura, M. Mizogami, and S. Fukuda Protamine sulfate causes endothelium-independent vasorelaxation via inducible nitric oxide synthase pathway: [Le sulfate de protamine cause un vasorelachement independant de l'endothelium par la voie de l'oxyde nitrique synthase inductible] Can J Anesth, February 1, 2006; 53(2): 162 - 167. [Abstract] [Full Text] [PDF]

				Y. Hamada, Y. Kameyama, H. Narita, K. T. Benson, and H. Goto Protamine After Heparin Produces Hypotension Resulting from Decreased Sympathetic Outflow Secondary to Increased Nitric Oxide in the Central Nervous System Anesth. Analg., January 1, 2005; 100(1): 33 - 37. [Abstract] [Full Text] [PDF]

				J.-S. David, B. Vivien, Y. Lecarpentier, P. Coriat, and B. Riou Extracellular Calcium Modulates the Effects of Protamine on Rat Myocardium Anesth. Analg., April 1, 2001; 92(4): 817 - 823. [Abstract] [Full Text] [PDF]

				G. Bushman Essentials of Nitric Oxide for the Pediatric (Cardiac) Anesthesiologist Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2001; 5(1): 79 - 90. [Abstract] [PDF]

				S. C. Body and S. K. Shernan The Utility of Nitric Oxide in the Postoperative Period Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30. [Abstract] [PDF]